Cargando…

Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection

Objectives. We investigated immune phenotypes of HIV+ patients who present late, considering late presenters (LPs, CD4+ < 350/μL and/or AIDS), advanced HIV disease (AHD, CD4+ < 200/μL and/or AIDS), and AIDS presenters (AIDS-defining condition at presentation, independently from CD4+). Methods....

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Francesca, Tincati, Camilla, Merlini, Esther, Pacioni, Carlotta, Sinigaglia, Elisabetta, Carpani, Giovanni, d'Arminio Monforte, Antonella, Marchetti, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205670/
https://www.ncbi.nlm.nih.gov/pubmed/22110905
http://dx.doi.org/10.1155/2012/314849
_version_ 1782215341553745920
author Bai, Francesca
Tincati, Camilla
Merlini, Esther
Pacioni, Carlotta
Sinigaglia, Elisabetta
Carpani, Giovanni
d'Arminio Monforte, Antonella
Marchetti, Giulia
author_facet Bai, Francesca
Tincati, Camilla
Merlini, Esther
Pacioni, Carlotta
Sinigaglia, Elisabetta
Carpani, Giovanni
d'Arminio Monforte, Antonella
Marchetti, Giulia
author_sort Bai, Francesca
collection PubMed
description Objectives. We investigated immune phenotypes of HIV+ patients who present late, considering late presenters (LPs, CD4+ < 350/μL and/or AIDS), advanced HIV disease (AHD, CD4+ < 200/μL and/or AIDS), and AIDS presenters (AIDS-defining condition at presentation, independently from CD4+). Methods. Patients newly diagnosed with HIV at our clinic between 2007–2011 were enrolled. Mann-Whitney/Chi-squared tests and logistic regression were used for statistics. Results. 275 patients were newly diagnosed with HIV between January/2007–March/2011. 130 (47%) were LPs, 79 (29%) showed AHD, and 49 (18%) were AIDS presenters. LP, AHD, and AIDS presenters were older and more frequently heterosexuals. Higher CD8+%, lower CD127+CD4+%, higher CD95+CD8+%, CD38+CD8+%, and CD45R0+CD38+CD8+% characterized LP/AHD/AIDS presentation. In multivariate analysis, older age, heterosexuality, higher CD8+%, and lower CD127+CD4+% were confirmed associated with LP/AHD. Lower CD4+ and higher CD38+CD8+% resulted independently associated with AIDS presentation. Conclusions. CD127 downregulation and immune activation characterize HIV+ patients presenting late and would be studied as additional markers of late presentation.
format Online
Article
Text
id pubmed-3205670
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-32056702011-11-22 Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection Bai, Francesca Tincati, Camilla Merlini, Esther Pacioni, Carlotta Sinigaglia, Elisabetta Carpani, Giovanni d'Arminio Monforte, Antonella Marchetti, Giulia AIDS Res Treat Research Article Objectives. We investigated immune phenotypes of HIV+ patients who present late, considering late presenters (LPs, CD4+ < 350/μL and/or AIDS), advanced HIV disease (AHD, CD4+ < 200/μL and/or AIDS), and AIDS presenters (AIDS-defining condition at presentation, independently from CD4+). Methods. Patients newly diagnosed with HIV at our clinic between 2007–2011 were enrolled. Mann-Whitney/Chi-squared tests and logistic regression were used for statistics. Results. 275 patients were newly diagnosed with HIV between January/2007–March/2011. 130 (47%) were LPs, 79 (29%) showed AHD, and 49 (18%) were AIDS presenters. LP, AHD, and AIDS presenters were older and more frequently heterosexuals. Higher CD8+%, lower CD127+CD4+%, higher CD95+CD8+%, CD38+CD8+%, and CD45R0+CD38+CD8+% characterized LP/AHD/AIDS presentation. In multivariate analysis, older age, heterosexuality, higher CD8+%, and lower CD127+CD4+% were confirmed associated with LP/AHD. Lower CD4+ and higher CD38+CD8+% resulted independently associated with AIDS presentation. Conclusions. CD127 downregulation and immune activation characterize HIV+ patients presenting late and would be studied as additional markers of late presentation. Hindawi Publishing Corporation 2012 2011-10-27 /pmc/articles/PMC3205670/ /pubmed/22110905 http://dx.doi.org/10.1155/2012/314849 Text en Copyright © 2012 Francesca Bai et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bai, Francesca
Tincati, Camilla
Merlini, Esther
Pacioni, Carlotta
Sinigaglia, Elisabetta
Carpani, Giovanni
d'Arminio Monforte, Antonella
Marchetti, Giulia
Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection
title Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection
title_full Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection
title_fullStr Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection
title_full_unstemmed Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection
title_short Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection
title_sort reduced central memory cd4+ t cells and increased t-cell activation characterise treatment-naive patients newly diagnosed at late stage of hiv infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205670/
https://www.ncbi.nlm.nih.gov/pubmed/22110905
http://dx.doi.org/10.1155/2012/314849
work_keys_str_mv AT baifrancesca reducedcentralmemorycd4tcellsandincreasedtcellactivationcharacterisetreatmentnaivepatientsnewlydiagnosedatlatestageofhivinfection
AT tincaticamilla reducedcentralmemorycd4tcellsandincreasedtcellactivationcharacterisetreatmentnaivepatientsnewlydiagnosedatlatestageofhivinfection
AT merliniesther reducedcentralmemorycd4tcellsandincreasedtcellactivationcharacterisetreatmentnaivepatientsnewlydiagnosedatlatestageofhivinfection
AT pacionicarlotta reducedcentralmemorycd4tcellsandincreasedtcellactivationcharacterisetreatmentnaivepatientsnewlydiagnosedatlatestageofhivinfection
AT sinigagliaelisabetta reducedcentralmemorycd4tcellsandincreasedtcellactivationcharacterisetreatmentnaivepatientsnewlydiagnosedatlatestageofhivinfection
AT carpanigiovanni reducedcentralmemorycd4tcellsandincreasedtcellactivationcharacterisetreatmentnaivepatientsnewlydiagnosedatlatestageofhivinfection
AT darminiomonforteantonella reducedcentralmemorycd4tcellsandincreasedtcellactivationcharacterisetreatmentnaivepatientsnewlydiagnosedatlatestageofhivinfection
AT marchettigiulia reducedcentralmemorycd4tcellsandincreasedtcellactivationcharacterisetreatmentnaivepatientsnewlydiagnosedatlatestageofhivinfection